A New Simple SCreening Tool for Painful Diabetic Neuropathy (ACT) in Ecuador.

IF 3.2 3区 医学 Q1 CLINICAL NEUROLOGY
Hoda Gad, María Cristina Moreno, Angel Pluas, María Belen Tello, Maribel Burgos, Karla Diaz, Estefanía Icaza, Mabel Sanchez, Mariella Vecchionacce, Rayaz A Malik, Carlos Solis
{"title":"A New Simple SCreening Tool for Painful Diabetic Neuropathy (ACT) in Ecuador.","authors":"Hoda Gad, María Cristina Moreno, Angel Pluas, María Belen Tello, Maribel Burgos, Karla Diaz, Estefanía Icaza, Mabel Sanchez, Mariella Vecchionacce, Rayaz A Malik, Carlos Solis","doi":"10.1111/jns.70118","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Diabetic painful neuropathy is a cause of significant disability and sleep disturbance but may be undiagnosed in up to 80% of patients with diabetes. Various neuropathic pain (NP) questionnaires have good diagnostic utility but are impractical in resource-constrained and busy clinical settings. A simple sCreening Tool (ACT) was developed as a concise, patient-led tool to rapidly detect NP. This study evaluates the screening validity and psychometric properties of ACT compared with the DN4 questionnaire (reference standard).</p><p><strong>Methods: </strong>We conducted an observational study employing clinic-based recruitment of patients with diabetes at a tertiary outpatient clinic in Guayaquil, Ecuador. All enrolled participants completed the ACT, DN4, and MNSI questionnaires during the study visit. MNSI was administered as part of the study to confirm the diagnosis of DPN using predefined cut-offs (MNSI-q ≥ 4 and MNSI-e ≥ 2.5). Time to completion, inter-item consistency, sensitivity, specificity, Youden's index, and the area under the receiver operating characteristic (ROC) curve were calculated for ACT using DN4 ≥ 4 as the criterion for NP.</p><p><strong>Results: </strong>Of the 300 participants (median age 63 years, diabetes duration 10 years), 65 (21.7%) had NP per DN4. Total ACTq+e (questionnaire+examination) yielded a cut-off score of ≥ 6 items as optimal, with area under the ROC curve 0.836, sensitivity 80.0% and specificity 75.7% for painful DPN. ACT demonstrated moderate internal consistency (Cronbach's alpha = 0.65) and was well received by patients and clinicians on face validity. The completion time for ACT was comparable to that of DN4.</p><p><strong>Conclusion: </strong>The ACT tool is a rapid screening tool for identifying neuropathic pain in the busy clinic, with acceptable sensitivity and specificity compared to DN4. The brevity and ease of patient self-administration of ACT make it promising for integration into busy outpatient workflows to improve the diagnosis of painful DPN.</p>","PeriodicalId":17451,"journal":{"name":"Journal of the Peripheral Nervous System","volume":"31 1","pages":"e70118"},"PeriodicalIF":3.2000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12999269/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Peripheral Nervous System","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/jns.70118","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Diabetic painful neuropathy is a cause of significant disability and sleep disturbance but may be undiagnosed in up to 80% of patients with diabetes. Various neuropathic pain (NP) questionnaires have good diagnostic utility but are impractical in resource-constrained and busy clinical settings. A simple sCreening Tool (ACT) was developed as a concise, patient-led tool to rapidly detect NP. This study evaluates the screening validity and psychometric properties of ACT compared with the DN4 questionnaire (reference standard).

Methods: We conducted an observational study employing clinic-based recruitment of patients with diabetes at a tertiary outpatient clinic in Guayaquil, Ecuador. All enrolled participants completed the ACT, DN4, and MNSI questionnaires during the study visit. MNSI was administered as part of the study to confirm the diagnosis of DPN using predefined cut-offs (MNSI-q ≥ 4 and MNSI-e ≥ 2.5). Time to completion, inter-item consistency, sensitivity, specificity, Youden's index, and the area under the receiver operating characteristic (ROC) curve were calculated for ACT using DN4 ≥ 4 as the criterion for NP.

Results: Of the 300 participants (median age 63 years, diabetes duration 10 years), 65 (21.7%) had NP per DN4. Total ACTq+e (questionnaire+examination) yielded a cut-off score of ≥ 6 items as optimal, with area under the ROC curve 0.836, sensitivity 80.0% and specificity 75.7% for painful DPN. ACT demonstrated moderate internal consistency (Cronbach's alpha = 0.65) and was well received by patients and clinicians on face validity. The completion time for ACT was comparable to that of DN4.

Conclusion: The ACT tool is a rapid screening tool for identifying neuropathic pain in the busy clinic, with acceptable sensitivity and specificity compared to DN4. The brevity and ease of patient self-administration of ACT make it promising for integration into busy outpatient workflows to improve the diagnosis of painful DPN.

Abstract Image

Abstract Image

Abstract Image

厄瓜多尔疼痛性糖尿病神经病变(ACT)的一种新的简单筛查工具。
背景:糖尿病性疼痛性神经病变是导致严重残疾和睡眠障碍的原因,但可能在高达80%的糖尿病患者中未被诊断。各种神经性疼痛(NP)问卷具有良好的诊断效用,但在资源有限和繁忙的临床设置是不切实际的。一个简单的筛选工具(ACT)被开发作为一个简洁的,病人主导的工具来快速检测NP。本研究比较了ACT与DN4问卷(参考标准)的筛选效度和心理测量学特性。方法:我们进行了一项观察性研究,在厄瓜多尔瓜亚基尔的一家三级门诊招募糖尿病患者。所有入组参与者在研究访问期间完成ACT、DN4和MNSI问卷调查。MNSI作为研究的一部分,使用预定义的截止值(MNSI-q≥4和MNSI-e≥2.5)来确认DPN的诊断。以DN4≥4作为NP的判定标准,计算ACT的完成时间、项目间一致性、敏感性、特异性、约登指数和受试者工作特征曲线下面积。结果:在300名参与者(中位年龄63岁,糖尿病持续时间10年)中,65名(21.7%)患有NP / DN4。总ACTq+e(问卷+检查)分值≥6项为最佳,ROC曲线下面积0.836,疼痛性DPN的敏感性80.0%,特异性75.7%。ACT表现出适度的内部一致性(Cronbach's alpha = 0.65),并且在面部效度上受到患者和临床医生的好评。ACT的完成时间与DN4相当。结论:在繁忙的临床中,ACT工具是一种快速识别神经性疼痛的筛查工具,与DN4相比,具有可接受的敏感性和特异性。ACT患者自我管理的简便性和便性使其有望融入繁忙的门诊工作流程,以提高疼痛DPN的诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.10
自引率
7.90%
发文量
45
审稿时长
>12 weeks
期刊介绍: The Journal of the Peripheral Nervous System is the official journal of the Peripheral Nerve Society. Founded in 1996, it is the scientific journal of choice for clinicians, clinical scientists and basic neuroscientists interested in all aspects of biology and clinical research of peripheral nervous system disorders. The Journal of the Peripheral Nervous System is a peer-reviewed journal that publishes high quality articles on cell and molecular biology, genomics, neuropathic pain, clinical research, trials, and unique case reports on inherited and acquired peripheral neuropathies. Original articles are organized according to the topic in one of four specific areas: Mechanisms of Disease, Genetics, Clinical Research, and Clinical Trials. The journal also publishes regular review papers on hot topics and Special Issues on basic, clinical, or assembled research in the field of peripheral nervous system disorders. Authors interested in contributing a review-type article or a Special Issue should contact the Editorial Office to discuss the scope of the proposed article with the Editor-in-Chief.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书